Article info

Download PDFPDF
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia

Authors

  • Catherine Prouvot Department of Gynecological Surgery and Oncology, Obstetrics, University Hospital Lyon Sud, University of Lyon 1; PubMed articlesGoogle scholar articles
  • François Golfier Department of Gynecological Surgery and Oncology, Obstetrics, University Hospital Lyon Sud, University of Lyon 1; French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite; PubMed articlesGoogle scholar articles
  • Jérôme Massardier French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite; Department of Prenatal Diagnosis, University Hospital Femme Mere Enfant, Bron; PubMed articlesGoogle scholar articles
  • Benoit You Department of Prenatal Diagnosis, University Hospital Femme Mere Enfant, Bron; Department of Medical Oncology, University Hospital Lyon Sud, University of Lyon 1, Pierre Bénite; PubMed articlesGoogle scholar articles
  • Jean-Pierre Lotz Department of Medical Oncology, Alliance for Cancer Research, Tenon Hospital, Public Assistance Hospitals of Paris, Paris; PubMed articlesGoogle scholar articles
  • Sophie Patrier Department of Pathology, University Hospital of Rouen, Rouen; PubMed articlesGoogle scholar articles
  • Mojgan Devouassoux Department of Pathology Croix Rousse Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1; and PubMed articlesGoogle scholar articles
  • Anne-Marie Schott French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite; Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche, Lyon, France. PubMed articlesGoogle scholar articles
  • Touria Hajri French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite; PubMed articlesGoogle scholar articles
  • Pierre-Adrien Bolze Department of Gynecological Surgery and Oncology, Obstetrics, University Hospital Lyon Sud, University of Lyon 1; French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite; PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Pierre-Adrien Bolze, MD, Centre Français des Maladies Trophoblastiques, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, Bâtiment 3B, 2ème étage 69495, Pierre Bénite, France. E-mail: pierre-adrien.bolze{at}chu-lyon.fr.

Citation

Prouvot C, Golfier F, Massardier J, et al
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia

Publication history

  • Received October 11, 2017
  • Accepted February 23, 2018
  • First published June 1, 2018.
Online issue publication 
June 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.